These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26307519)

  • 21. [Effects of fluid resuscitation on myocardial injury in patients with severe sepsis and septic shock].
    Zhang XL; Qin YJ; Bian XH; Dong SM
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr; 24(4):222-4. PubMed ID: 22464575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac markers (BNP, NT-pro-BNP, Troponin I, Troponin T, in female amateur runners before and up until three days after a marathon.
    Frassl W; Kowoll R; Katz N; Speth M; Stangl A; Brechtel L; Joscht B; Boldt LH; Meier-Buttermilch R; Schlemmer M; Roecker L; Gunga HC
    Clin Lab; 2008; 54(3-4):81-7. PubMed ID: 18630737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NT-ProBNP and cardiac troponin I in virulent canine babesiosis.
    Lobetti R; Kirberger R; Keller N; Kettner F; Dvir E
    Vet Parasitol; 2012 Dec; 190(3-4):333-9. PubMed ID: 22884910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevation of serum N-terminal pro-brain natriuretic peptide after exercise is an index of myocardial damage or a cytoprotective reflection?
    Faviou E; Zachari A; Nounopoulos C; Agrafiotis E; Vourli G; Dionyssiou-Asteriou A
    J Sports Med Phys Fitness; 2008 Mar; 48(1):90-6. PubMed ID: 18212715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure.
    Tsutamoto T; Kawahara C; Nishiyama K; Yamaji M; Fujii M; Yamamoto T; Horie M
    Am Heart J; 2010 Jan; 159(1):63-7. PubMed ID: 20102868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly - a randomised, double-blinded trial.
    Iwanuk N; Nolte I; Wall L; Sehn M; Raue J; Pilgram A; Rumstedt K; Bach JP
    BMC Vet Res; 2019 Jul; 15(1):237. PubMed ID: 31288807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of an endurance training program on exercise-induced cardiac biomarker release.
    Legaz-Arrese A; López-Laval I; George K; Puente-Lanzarote JJ; Mayolas-Pi C; Serrano-Ostáriz E; Revilla-Martí P; Moliner-Urdiales D; Reverter-Masià J
    Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H913-20. PubMed ID: 25681432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of long distance rowing on biological health: A pilot study.
    Frias MA; Virzi J; Golaz O; Gencer B; Mach F; Vuilleumier N
    Clin Biochem; 2018 Feb; 52():142-147. PubMed ID: 29198760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biologic variability in NT-proBNP and cardiac troponin-I in healthy dogs and dogs with mitral valve degeneration.
    Ruaux C; Scollan K; Suchodolski JS; Steiner JM; Sisson DD
    Vet Clin Pathol; 2015 Sep; 44(3):420-30. PubMed ID: 26108974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of a Soccer Game on Cardiac Biomarkers in Adolescent Players.
    Hosseini SM; Azizi M; Samadi A; Talebi N; Gatterer H; Burtscher M
    Pediatr Exerc Sci; 2018 Feb; 30(1):90-95. PubMed ID: 28661786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial Injury and Overload among Amateur Marathoners as Indicated by Changes in Concentrations of Cardiovascular Biomarkers.
    Kaleta-Duss AM; Lewicka-Potocka Z; Dąbrowska-Kugacka A; Raczak G; Lewicka E
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32859020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic value of analysis of H-FABP, NT-proBNP, and cTnI in heart function in children with congenital heart disease and pneumonia.
    Zhou FJ; Zhou CY; Tian YJ; Xiao AJ; Li PL; Wang YH; Jia JW
    Eur Rev Med Pharmacol Sci; 2014; 18(10):1513-6. PubMed ID: 24899611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive Values of N-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin I for Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy.
    Zhang C; Liu R; Yuan J; Cui J; Hu F; Yang W; Zhang Y; Chen Y; Qiao S
    PLoS One; 2016; 11(1):e0146572. PubMed ID: 26765106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-terminal pro-B-type natriuretic peptide as a marker of blunt cardiac contusion in trauma.
    Dogan H; Sarikaya S; Neijmann ST; Uysal E; Yucel N; Ozucelik DN; Okuturlar Y; Solak S; Sever N; Ayan C
    Int J Clin Exp Pathol; 2015; 8(6):6786-92. PubMed ID: 26261563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure.
    Rengo G; Pagano G; Parisi V; Femminella GD; de Lucia C; Liccardo D; Cannavo A; Zincarelli C; Komici K; Paolillo S; Fusco F; Koch WJ; Perrone Filardi P; Ferrara N; Leosco D
    Int J Cardiol; 2014 Feb; 171(3):384-9. PubMed ID: 24388546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Hall TS; Hallén J; Krucoff MW; Roe MT; Brennan DM; Agewall S; Atar D; Lincoff AM
    Am Heart J; 2015 Feb; 169(2):257-265.e1. PubMed ID: 25641535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure.
    Pastormerlo LE; Agazio A; Benelli E; Gabutti A; Poletti R; Prontera C; Clerico A; Emdin M; Passino C
    Am J Cardiol; 2015 Aug; 116(4):567-72. PubMed ID: 26089013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome.
    Eggers KM; Lagerqvist B; Oldgren J; Venge P; Wallentin L; Lindahl B
    Am Heart J; 2008 Sep; 156(3):588-94. PubMed ID: 18760145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy.
    Hijazi Z; Oldgren J; Andersson U; Connolly SJ; Ezekowitz MD; Hohnloser SH; Reilly PA; Vinereanu D; Siegbahn A; Yusuf S; Wallentin L
    Circulation; 2012 Apr; 125(13):1605-16. PubMed ID: 22374183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exercise oscillatory breathing and NT-proBNP levels in stable heart failure provide the strongest prediction of cardiac outcome when combining biomarkers with cardiopulmonary exercise testing.
    Guazzi M; Boracchi P; Labate V; Arena R; Reina G
    J Card Fail; 2012 Apr; 18(4):313-20. PubMed ID: 22464773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.